If you experience any severe or persistent side effects, you should contact your healthcare provider immediately
At 72 weeks, the 15 mg dose produced a mean weight loss of 22.5%
Biochemical Pathway Analysis suitable for analytical studies involving compound interaction and pathway response
Our data reveals a novel synergistic neuroprotection wherein N-3 PUFAs enhance VDR expression, thereby amplifying Vit Ds capacity to regulate gene networks involved in neuroprotection, and potentiating the anti-inflammatory and anti-apoptotic pathways, while tackling pathological protein aggregations, a common hallmark in multiple neurodegenerative diseases
Compared to placebo, the 120 microg three-times-daily and 360 microg two-times-daily doses of pramlintide resulted in additional weight loss of 3.2 kg and 3.3 kg at 4 months, and 6.1 kg and 7.2 kg at 12 months, respectively